Initiation - Spark Newswire

1 minute read

Being Cautious On Regulatory/Commercial Path, This Analyst Initiates Coverage On Verve Therapeutics

Today, 8:57 AM

Cantor Fitzgerald initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Neutral rating and a price target of $21. The analyst says…

VERV

1 minute read

Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock

By Vandana Singh

Today, 8:57 AM

Cantor Fitzgerald initiated coverage on Editas Medicine Inc (NASDAQ:EDIT) with an Overweight rating and a price target of $15. The analyst says…

CRSP

1 minute read

B of A Securities Initiates Coverage On New Fortress Energy with Buy Rating, Announces Price Target of $67

By Benzinga Newsdesk

Today, 8:57 AM

B of A Securities analyst Cameron Lochridge initiates coverage on New Fortress Energy (NASDAQ:NFE) with a Buy rating and announces Price Target of $67.

NFE

1 minute read

Mizuho Initiates Coverage On General Mills with Neutral Rating, Announces Price Target of $75

By Benzinga Newsdesk

Today, 8:57 AM

Mizuho analyst John Baumgartner initiates coverage on General Mills (NYSE:GIS) with a Neutral rating and announces Price Target of $75.

GIS

1 minute read

Cantor Fitzgerald Initiates Coverage On Intellia Therapeutics with Overweight Rating, Announces Price Target of $67

By Benzinga Newsdesk

Today, 8:57 AM

Cantor Fitzgerald analyst Rick Bienkowski initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Overweight rating and announces Price Target of $67.

NTLA

1 minute read

Cantor Fitzgerald Initiates Coverage On Beam Therapeutics with Overweight Rating, Announces Price Target of $62

By Benzinga Newsdesk

Today, 8:57 AM

Cantor Fitzgerald analyst Rick Bienkowski initiates coverage on Beam Therapeutics (NASDAQ:BEAM) with a Overweight rating and announces Price Target of $62.

BEAM

1 minute read

Lake Street Initiates Coverage On Zuora with Buy Rating, Announces Price Target of $11

By Benzinga Newsdesk

Today, 8:57 AM

Lake Street analyst Jacob Stephan initiates coverage on Zuora (NYSE:ZUO) with a Buy rating and announces Price Target of $11.

ZUO

1 minute read

LightShed Partners Initiates Coverage On Meta Platforms with Buy Rating, Announces Price Target of $200

By Benzinga Newsdesk

Today, 8:57 AM

LightShed Partners analyst Richard Greenfield initiates coverage on Meta Platforms (NASDAQ:META) with a Buy rating and announces Price Target of $200.